Inhibition of Myosin Light Chain Kinase Can Be Targeted for the Development of New Therapies Against HSV-1 Infection
Antiviral Therapy - United Kingdom
doi 10.3851/imp2661
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
International Medical Press